Published in Medical Devices and Surgical Technology Week, July 23rd, 2006
The article, titled "Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha (Multiferon(R)): A controlled, randomized multicenter trial," reports positive results for a category of melanoma patients for whom prognosis is generally poor. The article concludes that the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week